DK1618106T3 - Carbacephem beta-lactam antibiotika - Google Patents
Carbacephem beta-lactam antibiotikaInfo
- Publication number
- DK1618106T3 DK1618106T3 DK04750798.3T DK04750798T DK1618106T3 DK 1618106 T3 DK1618106 T3 DK 1618106T3 DK 04750798 T DK04750798 T DK 04750798T DK 1618106 T3 DK1618106 T3 DK 1618106T3
- Authority
- DK
- Denmark
- Prior art keywords
- carbacephem
- beta
- lactam antibiotics
- antibiotics
- methicillin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46698203P | 2003-04-30 | 2003-04-30 | |
PCT/US2004/013054 WO2004098500A2 (en) | 2003-04-30 | 2004-04-27 | CARBACEPHEM ss-LACTAM ANTIBIOTICS |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1618106T3 true DK1618106T3 (da) | 2010-03-15 |
Family
ID=33435002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04750798.3T DK1618106T3 (da) | 2003-04-30 | 2004-04-27 | Carbacephem beta-lactam antibiotika |
Country Status (10)
Country | Link |
---|---|
US (1) | US7109190B2 (da) |
EP (2) | EP2161268A1 (da) |
JP (1) | JP2006525340A (da) |
AT (1) | ATE449775T1 (da) |
CA (1) | CA2526875A1 (da) |
DE (1) | DE602004024297D1 (da) |
DK (1) | DK1618106T3 (da) |
ES (1) | ES2336917T3 (da) |
MX (1) | MXPA05011681A (da) |
WO (1) | WO2004098500A2 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090123367A1 (en) * | 2003-03-05 | 2009-05-14 | Delfmems | Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases |
CA2517145C (en) * | 2003-03-05 | 2017-08-01 | Halozyme, Inc. | Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
US20080146535A1 (en) * | 2003-04-30 | 2008-06-19 | Tomasz Glinka | Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors |
US8263613B2 (en) | 2007-02-16 | 2012-09-11 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab I inhibitors |
EA201070504A1 (ru) * | 2007-10-25 | 2010-12-30 | Эйкеоджен, Инк. | КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ |
WO2010030810A1 (en) * | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | Carbacephem beta-lactam antibiotics |
WO2010030811A2 (en) * | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | CARBACEPHEM β-LACTAM ANTIBIOTICS |
WO2010123997A1 (en) * | 2009-04-22 | 2010-10-28 | Achaogen, Inc. | Carbacephem beta-lactam antibiotics |
BR112020000196A2 (pt) | 2017-07-07 | 2020-07-07 | Epicentrx, Inc. | composições para administração parenteral de agentes terapêuticos |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60174787A (ja) * | 1984-02-21 | 1985-09-09 | Kyowa Hakko Kogyo Co Ltd | 3位置換カルバセフエム化合物 |
NO165842C (no) * | 1984-04-23 | 1991-04-17 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. |
US4788185A (en) * | 1984-04-23 | 1988-11-29 | Takeda Chemical Industries, Ltd. | Cephalosporin compounds |
JPH0830070B2 (ja) * | 1985-09-27 | 1996-03-27 | 武田薬品工業株式会社 | 抗菌性化合物 |
US4826834A (en) * | 1985-09-27 | 1989-05-02 | Takeda Chemical Industries, Ltd. | Cephem compounds |
US5077287A (en) * | 1991-01-18 | 1991-12-31 | Eli Lilly And Company | 3-thiazolylthio carbacephem antibacterial agents |
US5565445A (en) * | 1995-02-22 | 1996-10-15 | Merck & Co., Inc. | 3-thioheteroaryl 1-carba-1-dethiacephalosporin compounds, compositions and methods of use |
AR029004A1 (es) * | 1999-09-22 | 2003-06-04 | Essential Therapeutics Inc | Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana |
US6599893B2 (en) * | 2000-08-29 | 2003-07-29 | Essential Therapeutics, Inc. | Cephalosporin antibiotics and prodrugs thereof |
-
2004
- 2004-04-27 AT AT04750798T patent/ATE449775T1/de not_active IP Right Cessation
- 2004-04-27 JP JP2006513383A patent/JP2006525340A/ja active Pending
- 2004-04-27 DE DE602004024297T patent/DE602004024297D1/de not_active Expired - Lifetime
- 2004-04-27 WO PCT/US2004/013054 patent/WO2004098500A2/en active Application Filing
- 2004-04-27 EP EP09176059A patent/EP2161268A1/en not_active Withdrawn
- 2004-04-27 US US10/833,599 patent/US7109190B2/en not_active Expired - Fee Related
- 2004-04-27 CA CA002526875A patent/CA2526875A1/en not_active Abandoned
- 2004-04-27 ES ES04750798T patent/ES2336917T3/es not_active Expired - Lifetime
- 2004-04-27 EP EP04750798A patent/EP1618106B1/en not_active Expired - Lifetime
- 2004-04-27 DK DK04750798.3T patent/DK1618106T3/da active
- 2004-04-27 MX MXPA05011681A patent/MXPA05011681A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2526875A1 (en) | 2004-11-18 |
MXPA05011681A (es) | 2006-06-27 |
EP1618106B1 (en) | 2009-11-25 |
EP1618106A4 (en) | 2006-11-22 |
EP1618106A2 (en) | 2006-01-25 |
EP2161268A1 (en) | 2010-03-10 |
DE602004024297D1 (de) | 2010-01-07 |
JP2006525340A (ja) | 2006-11-09 |
WO2004098500A2 (en) | 2004-11-18 |
US20050004095A1 (en) | 2005-01-06 |
ATE449775T1 (de) | 2009-12-15 |
WO2004098500A3 (en) | 2005-06-02 |
ES2336917T3 (es) | 2010-04-19 |
US7109190B2 (en) | 2006-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400446A2 (hu) | Azitromicin kristályformái | |
NO20050210L (no) | Antibakterielle amid-makrocykluser | |
NO20055893L (no) | Nye linkomycinderivativer med antimikrobiell aktivitet | |
TW200507841A (en) | Antibacterial agents | |
MXPA05009352A (es) | Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas. | |
ATE344799T1 (de) | Piperidinderivate als antibakterielle mittel | |
MX2010004407A (es) | Antibioticos de carbacefem beta-lactama. | |
BRPI0414694A (pt) | pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas | |
ATE388153T1 (de) | Quervernetzte glycopeptid-cephalosporin- antibiotika | |
DK1618106T3 (da) | Carbacephem beta-lactam antibiotika | |
EP2495245A3 (en) | Gram-positive carbapenem antibacterials and processes for their preparation | |
ATE450540T1 (de) | Quervernetzte glycopeptid-cephalosporin- antibiotika | |
ATE556088T1 (de) | Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum | |
DK1434779T3 (da) | Tværbundne glycopeptid-cephalosporinantibiotika | |
WO2010030811A3 (en) | CARBACEPHEM β-LACTAM ANTIBIOTICS | |
CY1107038T1 (el) | Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης | |
DE60207884D1 (de) | Monobactam-antibakterielle verbindungen und anwendungsverfahren | |
MY136854A (en) | Crystalline n-formyl hydroxylamine compounds | |
ATE425984T1 (de) | Trizyklische antibakterielle makrolidderivate | |
DE60115851D1 (de) | Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind | |
WO2003068790A3 (en) | Macrolide antibacterial compounds | |
TH65156A (th) | การบำบัดรวมกันสำหรับการรักษาเกี่ยวกับการติดเชื้อแบคทีเรีย |